These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 6602640)

  • 1. Complement activation and generation of C3a anaphylatoxin by radiological contrast agents.
    Dawson P; Turner MW; Bradshaw A; Westaby S
    Br J Radiol; 1983 Jul; 56(667):447-8. PubMed ID: 6602640
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Angiography and complement activation. Evidence for generation of C3a anaphylatoxin by intravascular contrast agents.
    Westaby S; Dawson P; Turner MW; Pridie RB
    Cardiovasc Res; 1985 Feb; 19(2):85-8. PubMed ID: 3872180
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anaphylatoxin formation during hemodialysis: effects of different dialyzer membranes.
    Chenoweth DE; Cheung AK; Henderson LW
    Kidney Int; 1983 Dec; 24(6):764-9. PubMed ID: 6609269
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Complement activation and anaphylatoxin (C3a and C5a) formation in preeclampsia and by amniotic fluid.
    Haeger M; Bengtson A; Karlsson K; Heideman M
    Obstet Gynecol; 1989 Apr; 73(4):551-6. PubMed ID: 2784554
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anaphylatoxin generation in acute pancreatitis.
    Roxvall L; Bengtson A; Heideman M
    J Surg Res; 1989 Aug; 47(2):138-43. PubMed ID: 2787873
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Generation of C3a anaphylatoxin from human C3 by human mast cell tryptase.
    Schwartz LB; Kawahara MS; Hugli TE; Vik D; Fearon DT; Austen KF
    J Immunol; 1983 Apr; 130(4):1891-5. PubMed ID: 6339618
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The C terminus of the anaphylatoxin C3a generated upon complement activation represents a neoantigenic determinant with diagnostic potential.
    Burger R; Zilow G; Bader A; Friedlein A; Naser W
    J Immunol; 1988 Jul; 141(2):553-8. PubMed ID: 2454995
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anaphylatoxin generation in multisystem organ failure.
    Heideman M; Hugli TE
    J Trauma; 1984 Dec; 24(12):1038-43. PubMed ID: 6334754
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Generation of human C3a, C4a, and C5a anaphylatoxins by protein A of Staphylococcus aureus and immobilized protein A reagents used in serotherapy of cancer.
    Langone JJ; Das C; Bennett D; Terman DS
    J Immunol; 1984 Aug; 133(2):1057-63. PubMed ID: 6610702
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation of complement by radiographic contrast media: generation of chemotactic and anaphylatoxin activities.
    Till G; Rother U; Gemsa D
    Int Arch Allergy Appl Immunol; 1978; 56(6):543-50. PubMed ID: 415989
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anaphylatoxin formation during hemodialysis: comparison of new and re-used dialyzers.
    Chenoweth DE; Cheung AK; Ward DM; Henderson LW
    Kidney Int; 1983 Dec; 24(6):770-4. PubMed ID: 6609270
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complement activation during cardiopulmonary bypass: evidence for generation of C3a and C5a anaphylatoxins.
    Chenoweth DE; Cooper SW; Hugli TE; Stewart RW; Blackstone EH; Kirklin JW
    N Engl J Med; 1981 Feb; 304(9):497-503. PubMed ID: 7453783
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Generation and removal of anaphylatoxins during hemofiltration with five different membranes.
    Jørstad S; Smeby LC; Balstad T; Widerøe TE
    Blood Purif; 1988; 6(6):325-35. PubMed ID: 3264706
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased anaphylatoxins (C3a and C4a) in psoriatic sera.
    Ohkohchi K; Takematsu H; Tagami H
    Br J Dermatol; 1985 Aug; 113(2):189-96. PubMed ID: 3875363
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Generation of anaphylatoxin activity related to C3a, by treatment of human serum with the nitrogen nucleophile N2H4 or the chaotrope KSCN.
    von Zabern I; Damerau B; Nolte R; Grünefeld E; Vogt W
    Scand J Immunol; 1985 Dec; 22(6):639-51. PubMed ID: 3937227
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Complement activation produced by biomaterials.
    Chenoweth DE
    Artif Organs; 1988 Dec; 12(6):508-10. PubMed ID: 3265053
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dialysis leukopenia, hypoxemia, and anaphylatoxin formation: effect of membrane, bath, and citrate anticoagulation.
    Wiegmann TB; MacDougall ML; Diederich DA
    Am J Kidney Dis; 1988 May; 11(5):418-24. PubMed ID: 3259402
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of the third complement component (C3) and C3a generation in cardiac anaphylaxis: histamine release and associated inotropic and chronotropic effects.
    del Balzo U; Polley MJ; Levi R
    J Pharmacol Exp Ther; 1988 Sep; 246(3):911-6. PubMed ID: 2458450
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assays for plasma complement activation by x-ray contrast media.
    Eaton S; Tsay HM; Yost F; Tweedle MF
    Invest Radiol; 1990 Jul; 25(7):789-92. PubMed ID: 2391195
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anaphylatoxin generation and multisystem organ failure in acute pancreatitis.
    Roxvall L; Bengtson A; Heideman M
    Prog Clin Biol Res; 1989; 308():265-9. PubMed ID: 2789393
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.